1.
Babaloo H, Kouchakzade MA, Yazdanian A. Vascularized Immunoprotective Biomaterials as a Platform for β-Cell and Islet Replacement Therapy in Diabetes: Mechanisms and Translational Potential. J. App. Tiss. Eng. [Internet]. 2026 Oct. 5 [cited 2026 Oct. 22];12(3):68-7. Available from: https://www.journals.fmsbi.com/JATE/article/view/244